NCT07209254 Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension
| NCT ID | NCT07209254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jennifer Lewey, MD, MPH |
| Condition | Hypertension, Pregnancy Induced |
| Study Type | INTERVENTIONAL |
| Enrollment | 770 participants |
| Start Date | 2026-03-02 |
| Primary Completion | 2029-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 770 participants in total. It began in 2026-03-02 with a primary completion date of 2029-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Delivery within 14 days * Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum * Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum * English or Spanish speaking (able to read/understand consent and instructions) * Has phone texting capabilities Exclusion Criteria: * Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia) * Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery) * Chronic kidney disease (stage 3 or higher) * Using ≥3 BP medications at time of enrollment
Contact & Investigator
Jennifer Lewey, MD, MPH
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT07209254 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Hypertension, Pregnancy Induced. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07209254 currently recruiting?
Yes, NCT07209254 is actively recruiting participants. Contact the research team at Jennifer.Lewey@pennmedicine.upenn.edu for enrollment information.
Where is the NCT07209254 trial being conducted?
This trial is being conducted at New York, United States, Columbus, United States, Philadelphia, United States.
Who is sponsoring the NCT07209254 clinical trial?
NCT07209254 is sponsored by Jennifer Lewey, MD, MPH. The principal investigator is Jennifer Lewey, MD, MPH at University of Pennsylvania. The trial plans to enroll 770 participants.